title: Septic arthritis due to Salmonella enteritidis associated with infliximab use.
abstract: A unique case of septic arthritis caused by Salmonella enteritidis in a patient receiving infliximab for rheumatoid arthritis is presented. Antimicrobial chemotherapy with surgical intervention was necessary for eradication of the infection. Physicians should be aware of rare manifestations of Salmonella infections associated with infliximab use, especially in endemic areas.
authors.affiliation: Fourth Department of Internal Medicine, Attikon University General Hospital, Athens University Medical School, Athens, Greece. ikatsarolis@yahoo.com
authors.forename: Ioannis
authors.initials: I
authors.lastname: Katsarolis
authors.forename: Sotirios
authors.initials: S
authors.lastname: Tsiodras
authors.forename: Periklis
authors.initials: P
authors.lastname: Panagopoulos
authors.forename: Efthymia
authors.initials: E
authors.lastname: Giannitsioti
authors.forename: Grigorios
authors.initials: G
authors.lastname: Skarantavos
authors.forename: Theologos
authors.initials: T
authors.lastname: Ioannidis
authors.forename: Helen
authors.initials: H
authors.lastname: Giamarellou
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001170:Arthritis, Infectious / Q000139:chemically induced* / Q000382:microbiology; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D012480:Salmonella Infections / Q000139:chemically induced* / Q000382:microbiology; D012477:Salmonella enteritidis / Q000302:isolation & purification*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab